INOVIO PHARMACEUTICALS, INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Inovio Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Inovio Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -83.5 %, a 32% decline year-over-year.
  • Inovio Pharmaceuticals, Inc. annual Return On Assets for 2023 was -62.6 %, a 8.01% increase from 2022.
  • Inovio Pharmaceuticals, Inc. annual Return On Assets for 2022 was -68 %, a 27.6% decline from 2021.
  • Inovio Pharmaceuticals, Inc. annual Return On Assets for 2021 was -53.3 %, a 40.9% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -83.5 -20.3 -32% Jul 1, 2024 Sep 30, 2024
Q2 2024 -77.6 -23.3 -42.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -68.8 -2.97 -4.51% Jan 1, 2024 Mar 31, 2024
Q4 2023 -62.6 +5.45 +8.01% Oct 1, 2023 Dec 31, 2023
Q3 2023 -63.2 +10.9 +14.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -54.3 +18.9 +25.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -65.8 -2.37 -3.73% Jan 1, 2023 Mar 31, 2023
Q4 2022 -68 -14.7 -27.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -74.1 -36.1 -94.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -73.3 -47.8 -187% Apr 1, 2022 Jun 30, 2022
Q1 2022 -63.5 -27.2 -74.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -53.3 -15.5 -40.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -38.1 +14.6 +27.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -25.5 +56.9 +69.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -36.3 +25.1 +40.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -37.8 +35.4 +48.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -52.7 +19.1 +26.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -82.4 -8.15 -11% Apr 1, 2020 Jun 30, 2020
Q1 2020 -61.4 -0.04 -0.07% Jan 1, 2020 Mar 31, 2020
Q4 2019 -73.3 -8 -12.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 -71.8 -19.2 -36.5% Jul 1, 2019 Sep 30, 2019
Q2 2019 -74.3 -21.2 -40% Apr 1, 2019 Jun 30, 2019
Q1 2019 -61.3 -7.45 -13.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -65.3 -15.1 -30% Oct 1, 2018 Dec 31, 2018
Q3 2018 -52.6 +1.33 +2.47% Jul 1, 2018 Sep 30, 2018
Q2 2018 -53.1 -6.28 -13.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -53.9 -4.95 -10.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -50.2 -12.5 -33.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -53.9 -22.1 -69.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -46.8 -28.6 -157% Apr 1, 2017 Jun 30, 2017
Q1 2017 -49 -36.5 -294% Jan 1, 2017 Mar 31, 2017
Q4 2016 -37.7 -22.4 -146% Oct 1, 2016 Dec 31, 2016
Q3 2016 -31.8 -20.9 -191% Jul 1, 2016 Sep 30, 2016
Q2 2016 -18.2 +3.26 +15.2% Apr 1, 2016 Jun 30, 2016
Q1 2016 -12.4 +14.8 +54.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -15.3 +10.5 +40.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 -10.9 +23.3 +68% Jul 1, 2015 Sep 30, 2015
Q2 2015 -21.5 +36.3 +62.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -27.3 +44.5 +62% Jan 1, 2015 Mar 31, 2015
Q4 2014 -25.8 +66.7 +72.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -34.2 +50.4 +59.6% Jul 1, 2014 Sep 30, 2014
Q2 2014 -57.7 -3.46 -6.38% Apr 1, 2014 Jun 30, 2014
Q1 2014 -71.8 -30.5 -74% Jan 1, 2014 Mar 31, 2014
Q4 2013 -92.5 -51.9 -128% Oct 1, 2013 Dec 31, 2013
Q3 2013 -84.6 -37.8 -80.9% Jul 1, 2013 Sep 30, 2013
Q2 2013 -54.3 -15 -38.3% Apr 1, 2013 Jun 30, 2013
Q1 2013 -41.3 -7.17 -21% Jan 1, 2013 Mar 31, 2013
Q4 2012 -40.7 Oct 1, 2012 Dec 31, 2012
Q3 2012 -46.8 Jul 1, 2012 Sep 30, 2012
Q2 2012 -39.3 Apr 1, 2012 Jun 30, 2012
Q1 2012 -34.1 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.